Global Phenylketonuria Revenue Is Nearly 768 M USD In 2017
Thursday, 01 Nov, 2018
In the last several years, global market of Phenylketonuria developed rapidly, with an average growth rate of 5.31%. In 2017, global revenue of Phenylketonuria is nearly 768 M USD; the actual sales is about 6190 K units.

The classification of Phenylketonuria includes Medications and Supplements, and the revenue proportion of Medications in 2017 is about 53%, and the proportion is in increasing trend from 2013 to 2017.

Phenylketonuria is widely used in hospital and household. The most proportion of Phenylketonuria is used in hospital, and the consumption proportion in 2017 is about 75%.

North America is the largest consumption place, with a consumption market share nearly 45% in 2017. Following North America, Europe is the second largest consumption place with the market share of 27%.

Market competition is intense. Biomarin, Mead Johnson, Abbott, Nutricia?, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.